NANCY ASHMORE: Open Payments
NPI 1932561503 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 17 payments from 9 companies in 2025. Trend: 2023 $387 · 2024 $428 · 2025 $718
Food & beverage: $619Education: $99
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $113 |
| ABBVIE INC. | 1 | $113 |
| GlaxoSmithKline, LLC. | 7 | $113 |
| Astellas Pharma US Inc | 1 | $99 |
| Gilead Sciences, Inc. | 1 | $59 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $35 |
| Biogen, Inc. | 1 | $19 |
Products named: SYMPLICITY G3, Ozempic, VRAYLAR, TRELEGY ELLIPTA, Epclusa, Auvelity, Cologuard Collection Kit, SKYCLARYS.
Industry payments across TX — which companies pay providers there.
